Small molecules in oncology

Small molecules in oncology. Recent results in cancer research. Second edition. Editors P. M. Schlag & H.-J. Senn. Springer-Verlag (2014)


  1. Imatinib mesylate
  2. Dasatinib
  3. Nilotinib
  4. Bosutinib: a novel second-generation tyrosine kinase inhibitor
  5. Ponatinib: a third-generation inhibitor for the treatment of CML
  6. Erlotinib
  7. Lapatinib
  8. Sorafenib: targeting multiple tyrosine kinases in cancer
  9. Sunitinib in the treatment of advanced solid tumors
  10. Regorafenib
  11. Crizotinib
  12. Cabozantinib: a MET, RET, and VEGFR2 tyrosine kinase inhibitor
  13. Vemurafenib
  14. Dabrafenib
  15. Trametinib
  16. Ruxolitinib
  17. Ibrutinib
  18. Decitabine
  19. 5-Azacytidine/5-azacitidine
  20. Bortezomib
  21. Lenalidomide
  22. Pomalidomide
  23. Everolimus
  24. Temsirolimus
  25. Vismodegib

[contact-form-7 id=»5168″ title=»Контактная форма 1″]

0

Добавить комментарий

Войти с помощью: 

Ваш e-mail не будет опубликован. Обязательные поля помечены *